<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02031341</url>
  </required_header>
  <id_info>
    <org_study_id>KGINTDVR001</org_study_id>
    <nct_id>NCT02031341</nct_id>
  </id_info>
  <brief_title>Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals</brief_title>
  <acronym>PEAKS</acronym>
  <official_title>Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Impaired uptake of glucose by skeletal muscle is a key feature of type 2 diabetes mellitus.
      It is unclear to what extent impaired insulin uptake from capillaries into skeletal muscle
      interstitium plays a role in this process.

      We hypothesize that impaired uptake of insulin from capillaries into skeletal muscle
      interstitium is involved in impaired glucose uptake by skeletal muscle in type 2 diabetes
      mellitus.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fore-arm insulin uptake measured as ([A]-[V]) x F in pmol/min where A = arterial insulin concentrations, V= venous insulin concentrations, F = fore arm plasma flow;</measure>
    <time_frame>Baseline</time_frame>
    <description>During a single measure (thus cross-sectional) the primary endpoint will be measured.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Patients with type 2 diabetes mellitus</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoglycemic individuals</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood will be collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        50 subjects with T2DM and 50 nondiabetic individuals
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for all participants:

          -  written informed consent

          -  hemodynamically stable with a systolic blood pressure &gt; 100 mmHg

          -  medical need to undergo a CAG procedure as determined by cardiologist

        Exclusion criteria for all participants:

          -  ongoing myocardial infarction as determined from elevated cardiac markers

          -  participation in an investigational trial within 90 days prior to present study

          -  donation of blood (&gt; 100 mL) within 90 days prior to present study

          -  serious mental impairment or language problems i.e. preventing to understand the study
             protocol/aim

          -  Use or recent use (within 3 months of study participation) of oral glucocorticoids

        Inclusion criteria for non-diabetic individuals:

          -  30 years ≤ age ≤ 80 years (extremes included)

          -  fasting glucose level of &lt; 7.0 mmol/L and HbA1C &lt; 6.5% (= &lt; 48 mmol/mol)

        Exclusion criteria for non-diabetic individuals:

        - known T2DM/use of glucose-lowering medication

        Inclusion criteria for T2DM patients:

          -  30 years ≤ age ≤ 80 years (extremes included)

          -  fasting glucose level of &gt; 7.0 mmol/L, or HbA1C &gt; 6.5 (= &gt; 48 mmol/mol) or known T2DM

        Exclusion criteria for T2DM patients:

        - treatment with insulin preparations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kennemer Gasthuis</name>
      <address>
        <city>Haarlem</city>
        <zip>2023 KT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2014</study_first_submitted>
  <study_first_submitted_qc>January 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2014</study_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>D van Raalte</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

